Bionor Pharma ASA | Cash Flow
Fiscal year is January-December. All values NOK Thousands.
2013
2014
2015
2016
2017
Other Funds
-
-
1,334.00
-
13,712.00
Funds from Operations
71,408.00
58,773.00
84,475.00
52,785.00
69,159.00
166,592
Changes in Working Capital
2,842.00
5,694.00
2,406.00
36,893.00
500,465.00
833,824
Net Operating Cash Flow
68,566.00
64,467.00
82,069.00
15,892.00
431,306.00
667,232
Capital Expenditures
171.00
-
1,869.00
15,113.00
1,084.00
Sale of Fixed Assets & Businesses
-
-
-
152.00
96,224.00
Purchase/Sale of Investments
-
-
-
3,718.00
181.00
Net Investing Cash Flow
171.00
-
1,869.00
29,271.00
1,459.00
Cash Dividends Paid - Total
-
-
-
50,000.00
50,000.00
Issuance/Reduction of Debt, Net
3,000.00
-
-
15,757.00
416,692.00
Net Financing Cash Flow
67,362.00
50,057.00
1,413.00
71,351.00
541,970.00
Net Change in Cash
1,375.00
14,410.00
82,525.00
116,514.00
112,123.00
Free Cash Flow
68,737.00
64,467.00
83,938.00
779.00
432,390.00
Net Assets from Acquisitions
-
-
-
12,207.00
93,500.00
Other Sources
-
-
-
60,157.00
-
Change in Capital Stock
70,362.00
50,057.00
79.00
137,108.00
188,990.00
About Bionor Pharma ASA
View Profile
